Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 3
2006 1
2011 1
2012 3
2013 1
2014 1
2015 1
2016 2
2017 5
2018 3
2020 1
2021 3
2022 7
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Antibody mimicry, receptors and clinical applications.
Horenstein AL, Chillemi A, Quarona V, Zito A, Mariani V, Faini AC, Morandi F, Schiavoni I, Ausiello CM, Malavasi F. Horenstein AL, et al. Among authors: schiavoni i. Hum Antibodies. 2017;25(3-4):75-85. doi: 10.3233/HAB-160305. Hum Antibodies. 2017. PMID: 28035914 Review.
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronaviruses.
Mazzarella L, Santoro F, Ravasio R, Fumagalli V, Massa PE, Rodighiero S, Gavilán E, Romanenghi M, Duso BA, Bonetti E, Manganaro L, Pallavi R, Trastulli D, Pallavicini I, Gentile C, Monzani S, Leonardi T, Pasqualato S, Buttinelli G, Di Martino A, Fedele G, Schiavoni I, Stefanelli P, Meroni G, de Francesco R, Steinkuhler C, Fossati G, Iannacone M, Minucci S, Pelicci PG. Mazzarella L, et al. Among authors: schiavoni i. Sci Signal. 2023 Dec 19;16(816):eade0326. doi: 10.1126/scisignal.ade0326. Epub 2023 Dec 19. Sci Signal. 2023. PMID: 38113337
A 12-month follow-up of the immune response to SARS-CoV-2 primary vaccination: evidence from a real-world study.
Fedele G, Schiavoni I, Trentini F, Leone P, Olivetta E, Fallucca A, Fiore S, Di Martino A, Abrignani S, Baldo V, Baldovin T, Bandera A, Clerici P, De Paschale M, Diaco F, Domnich A, Fortunato F, Giberti I, Gori A, Grifantini R, Lazzarotto T, Lodi V, Mastroianni CM, Prato R, Restivo V, Vitale F, Brusaferro S, Merler S, Palamara AT, Stefanelli P; Study Group for the Immunological Monitoring post Covid19 vaccination. Fedele G, et al. Among authors: schiavoni i. Front Immunol. 2023 Nov 20;14:1272119. doi: 10.3389/fimmu.2023.1272119. eCollection 2023. Front Immunol. 2023. PMID: 38077369 Free PMC article.
Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study.
Fedele G, Trentini F, Schiavoni I, Abrignani S, Antonelli G, Baldo V, Baldovin T, Bandera A, Bonura F, Clerici P, De Paschale M, Fortunato F, Gori A, Grifantini R, Icardi G, Lazzarotto T, Lodi V, Mastroianni CM, Orsi A, Prato R, Restivo V, Carsetti R, Piano Mortari E, Leone P, Olivetta E, Fiore S, Di Martino A, Brusaferro S, Merler S, Palamara AT, Stefanelli P. Fedele G, et al. Among authors: schiavoni i. Front Immunol. 2022 Oct 31;13:1021396. doi: 10.3389/fimmu.2022.1021396. eCollection 2022. Front Immunol. 2022. PMID: 36389704 Free PMC article.
Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study.
Trevisan C, Raparelli V, Malara A, Abbatecola AM, Noale M, Palmieri A, Fedele G, Di Lonardo A, Leone P, Schiavoni I, Stefanelli P, Volpato S, Antonelli Incalzi R, Onder G; GeroCovid Vax working group. Trevisan C, et al. Among authors: schiavoni i. Intern Emerg Med. 2023 Aug;18(5):1337-1347. doi: 10.1007/s11739-023-03283-y. Epub 2023 Apr 29. Intern Emerg Med. 2023. PMID: 37120663 Free PMC article.
T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.
Schiavoni I, Palmieri A, Olivetta E, Leone P, Di Lonardo A, Mazzoli A, Cafariello C, Malara A, Palamara AT, Incalzi RA, Onder G, Stefanelli P, Fedele G; GeroCovid Vax CMI Study Group. Schiavoni I, et al. J Am Med Dir Assoc. 2023 Feb;24(2):140-147.e2. doi: 10.1016/j.jamda.2022.11.024. Epub 2022 Dec 7. J Am Med Dir Assoc. 2023. PMID: 36587928 Free PMC article.
A Third Dose of mRNA COVID-19 Vaccine Significantly Enhances Anti-SARS-CoV-2 Spike IgG Response in Nursing Home Residents in Italy.
Fedele G, Palmieri A, Malara A, Damiano C, Di Lonardo A, Schiavoni I, Leone P, Panduri G, Minchella P, Talarico F, Palamara AT, Stefanelli P, Incalzi RA, Onder G; GeroCovid Vax Study Group. Fedele G, et al. Among authors: schiavoni i. J Am Med Dir Assoc. 2022 Jul;23(7):1114-1115. doi: 10.1016/j.jamda.2022.05.006. Epub 2022 May 16. J Am Med Dir Assoc. 2022. PMID: 35661654 Free PMC article. No abstract available.
Anti-SARS-CoV-2 antibodies persistence after natural infection: a repeated serosurvey in Northern Italy.
Fedele G, Stefanelli P, Bella A, Fiore S, Pancheri S, Benedetti E, Fabiani C, Leone P, Vacca P, Schiavoni I, Neri A, Carannante A, Simmaco M, Santino I, Zuccali MG, Bizzarri G, Magnoni R, Benetollo PP, Brusaferro S, Rezza G, Ferro A. Fedele G, et al. Among authors: schiavoni i. Ann Ist Super Sanita. 2021 Oct-Dec;57(4):265-271. doi: 10.4415/ANN_21_04_01. Ann Ist Super Sanita. 2021. PMID: 35076416 Free article.
34 results